Alpha-1antitrypsin in pre-eclampsia; from a clinical perspective.

Area of Science:

• Obstetrics and Gynecology
• Biochemistry
• Pathophysiology

Background:

• Pre-eclampsia is a serious pregnancy complication.
• Understanding the biomarkers for pre-eclampsia is crucial for early detection and management.
• Alpha-1 antitrypsin (AAT) is an important protein with anti-inflammatory properties.

Purpose of the Study:

• To investigate serum Alpha-1 antitrypsin (AAT) levels in women diagnosed with pre-eclampsia.
• To determine the correlation between AAT levels and established pre-eclampsia severity parameters.

Main Methods:

• A case-control study involving 85 pregnant women (40 pre-eclamptic, 45 normotensive controls) at 32-34 weeks gestation.
• Serum AAT levels were measured and compared between groups.
• Correlations were analyzed between AAT levels and maternal age, blood pressure, uric acid, mean platelet volume (MPV), and platelet distribution width (PDW).

Main Results:

• Significantly lower serum AAT levels were observed in pre-eclamptic women (0.26 mg/dl) compared to normotensive controls (0.63 mg/dl).
• AAT levels showed significant negative correlations with systolic blood pressure (r=-0.43), diastolic blood pressure (r=-0.43), uric acid (r=-0.26), MPV (r=-0.25), and PDW (r=-0.25).

Conclusions:

• Lower serum AAT levels in pre-eclampsia suggest its potential contribution to the condition's development.
• The inverse correlation between AAT and key maternal parameters indicates its involvement in pre-eclampsia severity.
• Alpha-1 antitrypsin (AAT) is closely associated with the pathophysiology of pre-eclampsia, warranting further investigation.